26.11.2012 Views

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

achieved. The harmonisation process was initiated in order to minimise the<br />

confusion of having two very similar <strong>classification</strong> systems.<br />

It should be emphasised that there are many differences between the EphMRA<br />

<strong>classification</strong> <strong>and</strong> the <strong>ATC</strong> <strong>classification</strong>. This means that data prepared using the<br />

<strong>ATC</strong> <strong>classification</strong> cannot be directly compared with data prepared using the<br />

EphMRA system. The abbreviation <strong>ATC</strong> is un<strong>for</strong>tunately also used <strong>for</strong> the<br />

EphMRA <strong>classification</strong>, which can cause confusion.<br />

The EphMRA <strong>classification</strong> system is used worldwide by IMS (Intercontinental<br />

Medical Statistics) in producing marketing research statistics <strong>for</strong> the pharmaceutical<br />

industry.<br />

III. <strong>DDD</strong> (DEFINED DAILY DOSE)<br />

A. Definition <strong>and</strong> general considerations<br />

The basic definition of the unit is:<br />

The <strong>DDD</strong> is the assumed average maintenance dose per day <strong>for</strong> a drug used <strong>for</strong> its<br />

main indication in adults.<br />

A <strong>DDD</strong> will only be assigned <strong>for</strong> drugs that already have an <strong>ATC</strong> code.<br />

It should be emphasised that the defined daily dose is a unit of measurement <strong>and</strong><br />

does not necessarily reflect the recommended or Prescribed Daily Dose (see page<br />

31). Doses <strong>for</strong> individual patients <strong>and</strong> patient groups will often differ from the<br />

<strong>DDD</strong> <strong>and</strong> will necessarily have to be based on individual characteristics (e.g. age<br />

<strong>and</strong> weight) <strong>and</strong> pharmacokinetic considerations.<br />

For the optimal use of drugs, it is important to recognise that genetic polymorphism<br />

due to ethnic differences can result in variations in pharmacokinetics of drugs.<br />

However, only one single <strong>DDD</strong> is assigned per <strong>ATC</strong> code <strong>and</strong> route of<br />

administration. The <strong>DDD</strong> should reflect global dosage irrespective of genetic<br />

variations.<br />

Drug consumption data presented in <strong>DDD</strong>s only give a rough estimate of<br />

consumption <strong>and</strong> not an exact picture of actual use. <strong>DDD</strong>s provide a fixed unit of<br />

measurement independent of price, currencies, package size <strong>and</strong> strength enabling<br />

the researcher to assess trends in drug consumption <strong>and</strong> to per<strong>for</strong>m comparisons<br />

between population groups.<br />

22

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!